FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suparno Chakrabarti

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Parameswaran Anoop; David H Bevan; Suparno Chakrabarti
Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia.
H C E Buyck; S Ball; P Junagade; J Marsh; Suparno Chakrabarti
Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia.
Suparno Chakrabarti; Somnath Mukherjee
Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suparno Chakrabarti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Parameswaran Anoop; David H Bevan; Suparno Chakrabarti
Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia.
American journal of hematology 2009;84(5):312-3.
2009: H C E Buyck; S Ball; P Junagade; J Marsh; Suparno Chakrabarti
Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia.
Bone marrow transplantation 2009;43(10):813-6.
2009: Suparno Chakrabarti; Somnath Mukherjee
Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients.
Mediterranean journal of hematology and infectious diseases 2009;1(3):e2009017.
2007: Suparno Chakrabarti
Adenovirus infections after hematopoietic stem cell transplantation: still unravelling the story.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(8):966-8.
2007: Suparno Chakrabarti; Hubertus C E Buyck
Reduced-intensity transplantation in the treatment of haematological malignancies: current status and future-prospects.
Current stem cell research & therapy 2007;2(2):163-88.
2007: Jonathan M Cohen; Nichola Cooper; Suparno Chakrabarti; Kirsty Thomson; Sujith Samarasinghe; willoughby Cubitt; Cathryn Lloyd; Ann Woolfrey; Paul Veys; Persis J Amrolia
EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning.
Leukemia & lymphoma 2007;48(2):256-69.
2004: M Karanth; Suparno Chakrabarti; Richard Lovell; C Harvey; Kathleen Holder; C C McConkey; D McDonald; Christopher Fegan; Donald W Milligan
A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone.
Bone marrow transplantation 2004;34(5):399-403.
2004: Irit Avivi; Suparno Chakrabarti; panos kottaridis; C Kyriaku; Ahmet Dogan; Donald W Milligan; David C Linch; Anthony H Goldstone; Stephen Mackinnon
Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation.
Bone marrow transplantation 2004;34(2):137-42.
2004: Irit Avivi; Suparno Chakrabarti; Donald W Milligan; Herman Waldmann; Geoff Hale; Husam Osman; Katherine N Ward; Christopher Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Stephen Mackinnon
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):186-94.
2004: Suparno Chakrabarti; Husam Osman; Kathryn E Collingham; Christopher Fegan; Donald W Milligan
Enterovirus infections following T-cell depleted allogeneic transplants in adults.
Bone marrow transplantation 2004;33(4):425-30.
2004: Päivi M Lähteenmäki; Suparno Chakrabarti; Jacqueline M Cornish; Anthony Oakhill
Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease--comparison with a busulphan-cyclophosphamide regimen.
Acta oncologica (Stockholm, Sweden) 2004;43(2):196-203.
2004: Suparno Chakrabarti; David Bareford
Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(1):23-31.
2003: Suparno Chakrabarti; Donald W Milligan; Deenan Pillay; Stephen Mackinnon; Kathleen Holder; Narinder Kaur; Dorothy McDonald; Christopher Fegan; Herman Waldmann; Geoff Hale; Alan B Rickinson; Neil M Steven
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Blood 2003;102(3):839-42.
2003: Suparno Chakrabarti; Dorothy MacDonald; Geoff Hale; Kathleen Holder; Virginia Turner; Halina Czarnecka; Jacqui Thompson; Christopher Fegan; Herman Waldmann; Donald W Milligan
T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival.
British journal of haematology 2003;121(1):109-18.
2003: Suparno Chakrabarti; Husam Osman; Kathryn E Collingham; Donald W Milligan
Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning.
Bone marrow transplantation 2003;31(5):379-86.
2003: Suparno Chakrabarti
Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty.
Blood 2003;101(5):2071.
2003: Patricia A Cane; Bernadette van den Hoogen; Suparno Chakrabarti; Christopher Fegan; A D M E Osterhaus
Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.
Bone marrow transplantation 2003;31(4):309-10.
2002: Suparno Chakrabarti; Irit Avivi; Stephen Mackinnon; Kate Ward; panos kottaridis; Husam Osman; Herman Waldmann; Geoff Hale; Christopher Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Donald W Milligan
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.
British journal of haematology 2002;119(4):1125-32.
2002: Suparno Chakrabarti; Vivien Mautner; Husam Osman; Kathryn E Collingham; Christopher Fegan; Paul E Klapper; Paul A H Moss; Donald W Milligan
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.
Blood 2002;100(5):1619-27.
2002: Suparno Chakrabarti; Stephen Mackinnon; Raj Chopra; panos kottaridis; Karl S Peggs; Peter O'Gorman; Ronjon Chakraverty; Timothy Marshall; Husam Osman; Premini Mahendra; Charles Craddock; Herman Waldmann; Geoff Hale; Christopher Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Donald W Milligan
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Blood 2002;99(12):4357-63.
2002: Suparno Chakrabarti
Critical factors in optimizing graft-versus-leukemia effect for relapsed leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2756; author reply 2756-7.
2002: Suparno Chakrabarti
The place of rituximab in the treatment algorithm for post-stem cell transplant autoimmune hemolytic anemia.
Haematologica 2002;87(5):ELT23.
2002: Ronjon Chakraverty; Karl S Peggs; Rajesh Chopra; Donald W Milligan; panos kottaridis; Stephanie Verfuerth; Johanne Geary; Dharsha Thuraisundaram; Kate Branson; Suparno Chakrabarti; Premini Mahendra; Charles Craddock; Anne Parker; Ann Hunter; Geoff Hale; Herman Waldmann; Catherine D Williams; Kwee Yong; David C Linch; Anthony H Goldstone; Stephen Mackinnon
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Blood 2002;99(3):1071-8.
2001: Suparno Chakrabarti; Kathryn E Collingham; Husam Osman; Christopher Fegan; Donald W Milligan
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Bone marrow transplantation 2001;28(9):879-81.
2001: Suparno Chakrabarti; Kathryn E Collingham; T Marshall; Kathleen Holder; T Gentle; Geoff Hale; Christopher Fegan; Donald W Milligan
Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity.
Transplantation 2001;72(8):1460-3.
2001: Suparno Chakrabarti; Kathryn E Collingham; Kathleen Holder; Christopher Fegan; Husam Osman; Donald W Milligan
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Bone marrow transplantation 2001;28(8):759-63.
2001: Suparno Chakrabarti; S K Handa; R J Bryon; M J Griffiths; Donald W Milligan
Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
Transplantation 2001;72(2):340-2.
2001: panos kottaridis; Donald W Milligan; Rajesh Chopra; Ronjon Chakraverty; Suparno Chakrabarti; S Robinson; Karl S Peggs; Stephanie Verfuerth; Ruth Pettengell; Judith C W Marsh; Steve Schey; Premini Mahendra; Gareth J Morgan; Geoff Hale; Herman Waldmann; Mary Carmen Ruiz de Elvira; Catherine D Williams; Stephen Devereux; David C Linch; Anthony H Goldstone; Stephen Mackinnon
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Cytotherapy 2001;3(3):197-201.
2000: Suparno Chakrabarti; Kathryn E Collingham; Kathleen Holder; S Oyaide; Deenan Pillay; Donald W Milligan
Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(6):1516-8.
2000: Suparno Chakrabarti; A Lees; S G Jones; Donald W Milligan
Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality.
Bone marrow transplantation 2000;26(8):871-6.
2000: panos kottaridis; Donald W Milligan; Rajesh Chopra; Ronjon Chakraverty; Suparno Chakrabarti; S Robinson; Karl S Peggs; Stephanie Verfuerth; Ruth Pettengell; Judith C W Marsh; Steve Schey; Premini Mahendra; Gareth J Morgan; Geoff Hale; Herman Waldmann; M C de Elvira; Catherine D Williams; Stephen Devereux; David C Linch; Anthony H Goldstone; Stephen Mackinnon
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Blood 2000;96(7):2419-25.
2000: Suparno Chakrabarti; Kathryn E Collingham; Christopher Fegan; Deenan Pillay; Donald W Milligan
Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?
Bone marrow transplantation 2000;26(3):305-7.
2000: Suparno Chakrabarti; Kathryn E Collingham; R H Stevens; Deenan Pillay; Christopher Fegan; Donald W Milligan
Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study.
Bone marrow transplantation 2000;25(3):277-82.
1999: Suparno Chakrabarti; Kathryn E Collingham; Christopher Fegan; Donald W Milligan
Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy.
Bone marrow transplantation 1999;23(11):1209-11.